Texas is on the verge of enacting a controversial measure that would empower residents to sue out-of-state providers of abortion-inducing pills, setting the stage for a legal battle that could reshape how abortion laws are enforced across state lines. The bill, which has reached Governor Greg Abbott’s desk, is being hailed by supporters as a vital tool to uphold Texas’s abortion ban and protect women and fetuses. Opponents, however, see it as an intimidation tactic aimed at providers in other states who are legally dispensing the medication under their own laws.
The measure creates a unique form of citizen enforcement by allowing Texans to sue those who manufacture, transport, or provide abortion pills for use in the state, with penalties reaching up to $100,000. Women who receive and use the pills themselves would not be liable. Under its provisions, only the pregnant woman, the man who impregnated her, or close relatives would be entitled to collect the full amount, while other plaintiffs could receive just $10,000, with the remaining funds directed to charity. Lawmakers also included safeguards to prevent rapists or abusive partners from exploiting the law for financial gain and ensured that the identities and medical records of women seeking abortions would remain confidential.
The bill echoes Texas’ 2021 law that relied on citizen enforcement to restrict abortion, though this time the focus extends beyond state borders to target providers in Democratic-led states where shield laws protect them from out-of-state prosecution. The stakes are high, as abortion pills — particularly mifepristone — have become the most common method of abortion in the U.S. and remain widely accessible even in states enforcing near-total bans. Their availability through telehealth and mail services has been a key driver behind the national rise in abortion numbers despite local prohibitions.
The legal fight over abortion pills is already intensifying. Earlier this year, a Texas judge ordered a New York doctor to pay over $100,000 for supplying pills to a Texas woman, while Louisiana prosecutors filed criminal charges against her. New York has refused to enforce these rulings, citing its shield laws, but higher court rulings could challenge the strength of such protections. At the same time, Texas and several other conservative states are pushing lawsuits to roll back FDA approval of mifepristone, potentially forcing stricter in-person distribution requirements.
Abortion rights advocates argue the new Texas measure is designed to create a chilling effect, deterring out-of-state providers from helping Texas women. Anna Rupani of Fund Texas Choice said the law is another attempt by the state to control reproductive decisions and undermine women’s health care autonomy. If signed, the law will almost certainly face immediate constitutional challenges, setting the stage for yet another high-stakes showdown over abortion access in post-Roe America.
